These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 7769818
1. Potentiating effect of nicorandil, an antianginal agent, on relaxation induced by isoproterenol in isolated rat aorta: involvement of cyclic GMP-inhibitable cyclic AMP phosphodiesterase. Satake N, Zhou Q, Morikawa M, Inoue M, Shibata S. J Cardiovasc Pharmacol; 1995 Mar; 25(3):489-94. PubMed ID: 7769818 [Abstract] [Full Text] [Related]
2. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Delpy E, Coste H, Gouville AC. Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166 [Abstract] [Full Text] [Related]
3. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta. Yu SM, Kuo SC. Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926 [Abstract] [Full Text] [Related]
4. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery. Zhou Q, Satake N, Shibata S. Eur J Pharmacol; 1995 Jan 24; 273(1-2):153-9. PubMed ID: 7737309 [Abstract] [Full Text] [Related]
5. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Eckly AE, Lugnier C. Br J Pharmacol; 1994 Oct 24; 113(2):445-50. PubMed ID: 7834194 [Abstract] [Full Text] [Related]
6. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor. Yu SM, Cheng ZJ, Kuo SC. Eur J Pharmacol; 1995 Jun 23; 280(1):69-77. PubMed ID: 7498256 [Abstract] [Full Text] [Related]
15. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. Kukovetz WR, Holzmann S, Braida C, Pöch G. J Cardiovasc Pharmacol; 1991 Apr 23; 17(4):627-33. PubMed ID: 1711631 [Abstract] [Full Text] [Related]
16. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Gray DW, Marshall I. Br J Pharmacol; 1992 Nov 23; 107(3):684-90. PubMed ID: 1335334 [Abstract] [Full Text] [Related]
17. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors. Matsumoto T, Takahashi M, Omura T, Takaoka A, Liu Q, Nakae I, Kinoshita M. J Cardiovasc Pharmacol; 1997 Jun 23; 29(6):772-9. PubMed ID: 9234658 [Abstract] [Full Text] [Related]
18. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle. Yanagisawa T, Hashimoto H, Taira N. Br J Pharmacol; 1988 Oct 23; 95(2):393-8. PubMed ID: 2852521 [Abstract] [Full Text] [Related]
19. Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig. Jinno Y, Kasai H, Ohta H, Nishikori K, Fukushima H, Ogawa N. Br J Pharmacol; 1992 Aug 23; 106(4):906-9. PubMed ID: 1327392 [Abstract] [Full Text] [Related]